MedTrace Logo

Effects of Vaginal Seeding on Infants' Body Mass Index and Allergy Risk for Caesarean-delivered Children

NCT03809390 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2021-12-10

No results posted yet for this study

Summary

This is a single-blind randomized controlled trial, aiming to evaluate the effects of vaginal seeding on body mass index as well as allergy risk for cesarean-delivered infants. It will be conducted in Liuyang city of China, and the targeted sample size is 106. All the eligible pregnant women will be randomly assigned to either the intervention or control group, and their babies of the participants will be followed up to 24 months of age.

Conditions

  • Overweight and Obesity
  • Allergy

Interventions

PROCEDURE

Vaginal seeding

The same as that stated in arm descriptions.

Sponsors & Collaborators

  • National Natural Science Foundation of China

    collaborator OTHER_GOV

  • Liuyang Maternal and Child Health Care Hospital

    collaborator UNKNOWN

  • Peking University

    lead OTHER

Principal Investigators

  • Jian-meng Liu, PhD · Peking University

  • Hong-tian Li, PhD · Peking University

  • Shujin Zhou, MD · Liuyang Maternal and Child Health Care Hospital

  • Yang Liu, PhD Candidate · Peking University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-17
Primary Completion
2021-09-20
Completion
2022-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03809390 on ClinicalTrials.gov